Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays the completed glioblastoma trial record, including its eligibility criteria, treatment plan, outcome measures, and study documents, instead of an access-denied message.
    Difference
    51%
    Check dated 2026-11-08T10:27:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-01T11:41:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T11:48:26.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:55:21.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:36:24.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now serves a 403 Forbidden error, blocking access to the study details. The error page content, along with a Home link and a revision tag (Revision: v3.7.0), is now shown.
    Difference
    19%
    Check dated 2026-09-20T20:20:22.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.